Clinical Trials

40 enrolled

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07528417 2026-04-14

MYELO-CAN:ABX

75 enrolled

Myelodysplastic Syndromes, Myeloproliferative Disorders, Neutropenia, Leukemia, Myeloid, Acute

NCT07529951 2026-04-14

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

60 enrolled

Polycythemia Vera, Primary Myelofibrosis

NCT07153497 2026-04-13

Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)

132 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07469592 2026-04-13

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

LymphoidMyeloidOther hematologic neoplasm

165 enrolled

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07518940 2026-04-09

ENERGIA

25 enrolled

Motor Activity, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07254793 2026-04-07

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

LymphoidMyeloidOther hematologic neoplasm

94 enrolled

Lymphoma, Non-Hodgkin, Motor Activity, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07454850 2026-03-31

A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait

400 enrolled

Phase 3 Not yet recruiting

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT07489755 2026-03-24

TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients

180 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT05969821 2026-03-23

CHIS

LymphoidMyeloidOther hematologic neoplasm

5,000 enrolled

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT07354074 2026-03-23

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

50 enrolled

Phase 1/2 Not yet recruiting

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT07387354 2026-03-16

MDS

25 enrolled

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT07468916 2026-03-13

Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia

35 enrolled

Phase 1/2 Not yet recruiting

Myeloproliferative Disorders, Thrombocytosis, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT07372885 2026-03-11

GRACE

50 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07449286 2026-03-04

IFN-α in Relapse Prevention.

100 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07445893 2026-03-03

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

30 enrolled

Phase 2/3 Not yet recruiting

Polycythemia Vera

NCT07440290 2026-02-27

DETERMINE

30 enrolled

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT07429266 2026-02-24

A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

Phase 3 Not yet recruiting

250 enrolled

Polycythemia Vera

NCT07413263 2026-02-18

Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

75 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT07394153 2026-02-06

PACRIMYEL

30 enrolled

Primary Myelofibrosis

NCT07384039 2026-02-05

MPN-Exercise

80 enrolled

Myeloproliferative Disorders

NCT07379125 2026-01-30

Therapeutic RSK1 Targeting in Myelofibrosis

Classical hematologyMyeloid

18 enrolled

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT07349134 2026-01-20

WELL-MPN

75 enrolled

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT07347418 2026-01-16

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS

23 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07341048 2026-01-15

ACTIVAQ

54 enrolled

Phase 1/2 Not yet recruiting

Polycythemia, Polycythemia Vera

NCT07332858 2026-01-14

First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion

105 enrolled

MyeloidThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT07319793 2026-01-06

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

200 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT07249476 2025-12-16

ENKLA-M

55 enrolled

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07269470 2025-12-16

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

40 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT07264959 2025-12-04

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

150 enrolled

Mastocytosis, Mastocytosis, Systemic

NCT07007052 2025-11-26

TAGVEN

33 enrolled

Pathologic Complete Response, Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT07249840 2025-11-25

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

12 enrolled

Myeloproliferative Disorders

NCT06987058 2025-09-24

ROVER-01

10 enrolled

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Myeloid, Acute

NCT07158294 2025-09-05

DiP-in-CML

150 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT07146542 2025-08-28

Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia

66 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT07108023 2025-08-06

EHPVO-HEM

Classical hematologyMyeloid

115 enrolled

Anemia, Hematologic Diseases, Hemoglobinuria, Paroxysmal, Hypersplenism, Leukopenia, Myeloproliferative Disorders, Thrombocytopenia, Antiphospholipid Syndrome, Thrombophilia

NCT06290765 2025-07-31

PV

Phase 4 Not yet recruiting

70 enrolled

Myeloproliferative Disorders, Polycythemia Vera

NCT07012109 2025-06-10

Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

90 enrolled

Polycythemia Vera

NCT06996119 2025-05-30

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

15 enrolled

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06923670 2025-05-15

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

496 enrolled